Generic Database of Moderate Preterm Infants
Time Limited Observational Study of the Moderately Preterm Infant (29 0/7 - 33 6/7 Weeks)
20 other identifiers
observational
7,057
1 country
19
Brief Summary
This is a registry of moderate preterm infants, born alive at 29-33 weeks gestational age, in NICHD Neonatal Research Network (NRN) centers. The registry collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and trends between baseline information, treatments, and infant outcome, and to develop future NRN trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2012
19 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 13, 2013
CompletedFirst Posted
Study publicly available on registry
February 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedMarch 22, 2019
March 1, 2019
1.6 years
February 13, 2013
March 20, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of infants born moderately preterm
Number of infants born between 29-33 weeks gestational age at 18 participating NRN centers.
up to 2 years
Eligibility Criteria
Moderately preterm infants born at 29 0/7 weeks to 33 6/7 weeks-both inborn and outborn but admitted prior to 72 hours at NRN centers will be included in this study.
You may qualify if:
- Gestational age 29-33 weeks
- Inborn infants and outborn infants admitted by 72 hours.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (19)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
University of California - Los Angeles
Los Angeles, California, 90025, United States
Stanford University
Palo Alto, California, 94304, United States
Emory University
Atlanta, Georgia, 30303, United States
Indiana University
Indianapolis, Indiana, 46202, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Wayne State University
Detroit, Michigan, 48201, United States
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
University of New Mexico
Albuquerque, New Mexico, 87131, United States
University of Rochester
Rochester, New York, 14642, United States
RTI International
Durham, North Carolina, 27705, United States
Duke University
Durham, North Carolina, 27710, United States
Cincinnati Children's Medical Center
Cincinnati, Ohio, 45267, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
Research Institute at Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Univeristy of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, 02905, United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75235, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Abbot R Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
- PRINCIPAL INVESTIGATOR
Michele C Walsh, MD, MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
- PRINCIPAL INVESTIGATOR
Ronald N Goldberg, MD
Duke University
- PRINCIPAL INVESTIGATOR
Barbara J Stoll, MD
Emory University
- PRINCIPAL INVESTIGATOR
Brenda B Poindexter, MD, MS
Indiana University
- PRINCIPAL INVESTIGATOR
Abhik Das, PhD
RTI International
- PRINCIPAL INVESTIGATOR
Krisa P Van Meurs, MD
Stanford University
- PRINCIPAL INVESTIGATOR
Kurt Schibler, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Waldemar Carlo, MD
University of Alabama at Birmingha
- PRINCIPAL INVESTIGATOR
Edward F Bell, MD
University of Iowa
- PRINCIPAL INVESTIGATOR
Kristi L Watterberg, MD
University of New Mexico
- PRINCIPAL INVESTIGATOR
Pablo J Sanchez, MD
University of Texas, Southwestern Medical Center at Dallas
- PRINCIPAL INVESTIGATOR
Kathleen A Kennedy, MD, MPH
The University of Texas Health Science Center, Houston
- PRINCIPAL INVESTIGATOR
Seetha Shankaran, MD
Wayne State University
- PRINCIPAL INVESTIGATOR
William Truog, MD
Abbot R Laptook, MD Study Principal Investigator Brown University, Women & Infants Hospital of Rhode Island Michele C Walsh, MD MS Study Principal Investigator Case Western Reserve University, Rainbow Babies and Children's Hospital Ronald N Goldberg,
- PRINCIPAL INVESTIGATOR
Barbara Schmidt, MD, MSc
University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Carl D'Angio, MD
University of Rochester
- PRINCIPAL INVESTIGATOR
Uday Devaskar, MD
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Leif Nelin, MD
Research Institute at Nationwide Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 11 Weeks
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2013
First Posted
February 15, 2013
Study Start
March 1, 2012
Primary Completion
October 1, 2013
Study Completion
February 1, 2014
Last Updated
March 22, 2019
Record last verified: 2019-03